This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sharp HealthCare And Nonprofit FHCE To Present Software Answer To $49 Billion Hospital Industry Shortfall With Results From 25-Month ER Study

SAN MATEO, Calif., Feb. 27, 2013 /PRNewswire/ -- While thousands of hospitals struggle to find better ways to meet the needs of uninsured and private pay patients, Sharp HealthCare  will present a welcome solution with findings from a 25-month study of uninsured  patients cared for at its four busy San Diego ERs.  In an innovative partnership with the Foundation for Health Coverage Education (FHCE), Sharp will shed new light on how hospitals can gain reimbursement while providing patients with much-needed assistance at the annual Health Information Management Systems Society (HIMSS) conference in New Orleans, Monday, March 4.


The architects of the new approach, Gerilynn Sevenikar, vice president of Patient Financial Services for Sharp HealthCare, and Ankeny Minoux, president of FHCE, will present  "How Hospitals Can Improve their Bottom Line and Relationships with Uninsured Patients," covering the lessons learned and steps other hospitals can take, at 9:45 a.m. in room 347 of the Ernest N. Morial Convention Center.

Minoux and Sevenikar will share insights into the Sharp approach, which has its genesis in FHCE's free Eligibility Quiz that allows uninsured ER patients to identify which public and private low-cost coverage options for which they may qualify through a simple, 90-second, five-step quiz. During the 25-month study, Sharp discovered more than 80% of the patients who took the survey were not enrolled in free or low-cost government programs for which they were eligible.

Armed with this critical insight, Sevenikar and her team at Sharp, working closely with FHCE, further refined the approach by incorporating the FHCE coverage and enrollment data along with the organization's admitting protocols and financial systems. The end result made it possible for every ER patient to receive a list of available coverage options during the point-of-care step.   

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs